Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma × mirvetuximab soravtansine × 90 days × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 5 Ovarian Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡